CD Targeted Cell Therapy Market Size, Share & Trends Analysis Report By Indication Type (Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Acute Lymphoblastic Leukemia, and Others), By Target Type, Region And Segment Forecasts, 2023-2031.

Chapter 1.Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2.Executive Summary

Chapter 3.Global CD Targeted Cell Therapy Market Snapshot

Chapter 4.Global CD Targeted Cell Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5.Market Segmentation 1: By Indication Type Estimates & Trend Analysis
5.1. By Indication Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Indication Type:
5.2.1. Diffuse large B-cell lymphoma
5.2.2. Chronic lymphocytic leukemia
5.2.3. Multiple myeloma
5.2.4. Acute lymphoblastic leukemia
5.2.5. Others

Chapter 6.Market Segmentation 2: By Target Type Estimates & Trend Analysis
6.1. By Target Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Target Type:
6.2.1. CD19
6.2.2. CD20
6.2.3. CD33

Chapter 7.CD Targeted Cell Therapy Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Indication Type, 2023-2031
7.1.2. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.1.3. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.1.3.1. U.S.
7.1.3.2. Canada

7.2. Europe
7.2.1. Europe CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031
7.2.2. Europe CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.2.3. Europe CD Targeted Cell Therapy Market revenue (US$ Million) by country, 2023-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe

7.3. Asia Pacific
7.3.1. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031
7.3.2. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.3.3. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) by country, 2023-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific

7.4. Latin America
7.4.1. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031
7.4.2. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.4.3. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America

7.5. Middle East & Africa
7.5.1. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, (US$ Million)
7.5.2. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.5.3. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA

Chapter 8.Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles

8.2.1. Juno Therapeutics
8.2.2. Agios Pharmaceutical
8.2.3. Aurora BioPharma
8.2.4. Atara Biotherapeutics
8.2.5. AryoGen Biopharma
8.2.6. Shenzhen BinDeBio Ltd.
8.2.7. China Immunotech Co., Ltd.
8.2.8. Autolus Limited
8.2.9. Kite Pharma
8.2.10. Bellicum Pharmaceuticals
8.2.11. bluebird bio
8.2.12. Calibr
8.2.13. Carina Biotech
8.2.14. CARsgen Therapeutics
8.2.15. Celgene Corporation
8.2.16. Cellectis
8.2.17. Cell Medica
8.2.18. AbbVie
8.2.19. Allogene Therapeutics
8.2.20. Amgen
8.2.21. Cell Design Labs
8.2.22. Celularity
8.2.23. Celyad
8.2.24. Fate Therapeutics
8.2.25. Fortress Bio
8.2.26. Gilead Sciences
8.2.27. Sorrento Therapeutics, Inc.
8.2.28. Ziopharm
8.2.29. Janssen Biotech
8.2.30. JW Therapeutics
8.2.31. Medisix Therapeutics
8.2.32. Mustang Bio
8.2.33. Nanjing Legend Biotech
8.2.34. Precision Biosciences
8.2.35. Posedia Therapeutics
8.2.36. Other Prominent Players

Global CD Targeted Cell Therapy Market Segmentation:

Global CD Targeted Cell Therapy Market by Indication Type

• Diffuse large B-cell lymphoma
• Chronic lymphocytic leukemia
• Multiple myeloma
• Acute lymphoblastic leukemia
• Others

Global CD Targeted Cell Therapy Market by Target Type

• CD19
• CD20
• CD33

Global CD Targeted Cell Therapy Market Based on Region

Europe CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

North America CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

• U.S.
• Canada

Asia Pacific CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

• GCC Countries
• South Africa
• Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.